Insulin sensitizer prevents and ameliorates experimental type 1 diabetes

In conclusion, potent insulin sensitizers may counteract genetic predisposition to autoimmune T1D and amplify subtherapeutic insulin into an effective therapeutic measure for the treatment of overt T1D.

Source: AJP: Endocrinology and Metabolism - December 1, 2017 Category: Endocrinology Authors: Valitsky, M., Hoffman, A., Unterman, T., Bar-Tana, J. Tags: Research Article Source Type: research